US2017240698A1PendingUtilityA1

Biodegradable Stealth Polymeric Particles Fabricated Using The Macromonomer Approach By Free Radical Dispersion Polymerization

44
Assignee: AKALA EMMANUEL OYEKANMIPriority: Nov 23, 2010Filed: May 9, 2017Published: Aug 24, 2017
Est. expiryNov 23, 2030(~4.4 yrs left)· nominal 20-yr term from priority
A61P 35/00C08G 63/912Y10S977/773B82Y 40/00C08G 63/78B82Y 15/00B01J 13/16A61K 9/1635B82Y 5/00A61K 31/337C08F 299/024A61K 9/5153C08G 63/06A61K 31/704B01J 13/06A61K 31/7034Y10T428/2982C08G 63/82C08G 63/85
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to a crosslinked or non-crosslinked polymer particle, wherein the crosslinked polymer particle comprises a copolymer of poly(alkylene glycol-graft-lactate) that is crosslinked by at least one hydrolysable monomer. Another embodiment of the present invention is a polymer particle comprising a crosslinked polymer particle that is a product of starting materials comprising (a) a hydrophilic monomer, (b) a hydrophobic monomer, and (c) a hydrolysable crosslinking agent. Another embodiment of the present invention is a polymer particle comprising, a crosslinked copolymer comprising structures represented by Formulas (I), (II), and (III), where Formulas (I), (II) and (III) are defined in the specification. Yet other embodiments of the present invention include a method of preparing a methacrylate terminated macromonomer, a method of preparing a crosslinking agent, and a method of preparing a therapeutic agent loaded nanosphere by dispersion polymerization.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of preparing a methacrylate terminated macromonomer, the method comprising the steps of:
 (i) reacting L-lactide, an initiator and a catalyst under vacuum for 10 minutes   (ii) flushing the reaction vessel with nitrogen for 24 to 38 hours at a temperature of 120-240° C.   (iii) extracting the resulting polymer from an organic solution.   
     
     
         2 . The method of  claim 1 , wherein the initiator is selected from the group consisting of hydroxymethacrylate (HEMA) or hydroxylpropylmethacrylamide (HPMA). 
     
     
         3 . The method of  claim 1 , wherein the amount of L-lactide is 0.0418 moles. 
     
     
         4 . The method of  claim 1 , wherein the amount of initiator is 0.00738 mole.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.